Colecchia, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.018
AS - Asia 11.630
EU - Europa 7.481
SA - Sud America 2.857
AF - Africa 289
OC - Oceania 94
Continente sconosciuto - Info sul continente non disponibili 11
Totale 34.380
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.628
SG - Singapore 2.990
CN - Cina 2.868
SE - Svezia 2.304
BR - Brasile 2.265
HK - Hong Kong 2.006
VN - Vietnam 1.522
IT - Italia 1.487
GB - Regno Unito 924
FI - Finlandia 857
BD - Bangladesh 558
KR - Corea 542
RU - Federazione Russa 419
DE - Germania 304
AR - Argentina 240
PL - Polonia 239
ID - Indonesia 223
BG - Bulgaria 207
IN - India 177
CA - Canada 173
FR - Francia 172
EC - Ecuador 132
JP - Giappone 132
MX - Messico 114
NL - Olanda 111
AU - Australia 82
TR - Turchia 78
IQ - Iraq 73
ZA - Sudafrica 69
UA - Ucraina 67
PK - Pakistan 64
IE - Irlanda 59
CO - Colombia 54
ES - Italia 52
AT - Austria 49
EG - Egitto 47
CL - Cile 44
AE - Emirati Arabi Uniti 43
PY - Paraguay 42
MA - Marocco 40
RO - Romania 40
UZ - Uzbekistan 39
LT - Lituania 38
PH - Filippine 36
IR - Iran 30
TH - Thailandia 30
TN - Tunisia 30
VE - Venezuela 30
KE - Kenya 25
BE - Belgio 23
MY - Malesia 22
PE - Perù 22
AZ - Azerbaigian 19
CZ - Repubblica Ceca 19
JM - Giamaica 19
NP - Nepal 19
UY - Uruguay 19
JO - Giordania 17
SA - Arabia Saudita 17
DZ - Algeria 16
TW - Taiwan 14
BH - Bahrain 13
CR - Costa Rica 13
KZ - Kazakistan 13
CH - Svizzera 12
MK - Macedonia 12
LB - Libano 11
PT - Portogallo 11
AL - Albania 10
DO - Repubblica Dominicana 10
GR - Grecia 10
PA - Panama 10
SC - Seychelles 10
BO - Bolivia 9
HN - Honduras 9
IL - Israele 9
KG - Kirghizistan 9
NZ - Nuova Zelanda 9
NG - Nigeria 8
NI - Nicaragua 8
ET - Etiopia 7
GH - Ghana 7
GT - Guatemala 7
OM - Oman 7
PS - Palestinian Territory 7
QA - Qatar 7
DK - Danimarca 6
EU - Europa 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
BB - Barbados 5
HU - Ungheria 5
KH - Cambogia 5
MD - Moldavia 5
PR - Porto Rico 5
TT - Trinidad e Tobago 5
BY - Bielorussia 4
CY - Cipro 4
GE - Georgia 4
HR - Croazia 4
Totale 34.289
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.040
Hong Kong 1.973
Stockholm 1.792
Singapore 1.620
Ashburn 1.357
Helsinki 817
Hefei 773
San Jose 676
Fairfield 645
London 620
Ho Chi Minh City 516
Nyköping 472
Seoul 450
Beijing 441
The Dalles 384
Hanoi 360
Chandler 331
Los Angeles 309
Council Bluffs 304
New York 269
São Paulo 265
Wilmington 262
Princeton 239
Woodbridge 232
San Diego 229
Houston 228
Milan 227
Warsaw 224
Buffalo 207
Sofia 204
Cambridge 203
Shanghai 185
Chicago 163
Seattle 163
Jakarta 115
Modena 101
Rome 98
Dallas 96
Bologna 93
Moscow 91
Da Nang 81
Porto Alegre 73
Rio de Janeiro 71
Salt Lake City 70
Melbourne 68
Tokyo 68
Redondo Beach 67
Haiphong 66
Orem 64
Nuremberg 63
Lauterbourg 58
Southend 57
Ann Arbor 56
Phoenix 54
Piscataway 54
Bupyeong-gu 53
Belo Horizonte 50
Dublin 50
Frankfurt am Main 49
Kent 44
Quito 44
Elk Grove Village 42
Guangzhou 42
Munich 42
Amsterdam 41
Jacksonville 40
Curitiba 39
North Bergen 39
Biên Hòa 38
Guayaquil 38
Jersey City 38
Bremen 37
Chennai 34
Johannesburg 34
Miano 34
Tashkent 34
Vancouver 34
Atlanta 33
Hải Dương 32
Reggio Emilia 32
Dhaka 31
Naples 31
Montreal 30
Tampa 30
Kilburn 29
Secaucus 29
Brasília 28
Boardman 27
Norwalk 27
Baghdad 25
Campinas 25
Clifton 25
Denver 25
Florence 25
Ninh Bình 24
Palermo 24
Brooklyn 23
Buenos Aires 23
Toronto 23
Columbus 22
Totale 22.263
Salva come PNG Salva come JPEG
Nome #
"Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?" 1.969
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma 354
Gut Microbiota and Celiac Disease. 321
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 317
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study 289
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT 289
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 277
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 275
Adverse Food Reaction and Functional Gastrointestinal Disorders: Role of the Dietetic Approach 272
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study. 271
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices 271
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure. 255
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project) 255
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 237
Role of Vitamin D in Liver Disease and Complications of Advanced Chronic Liver Disease 235
A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease 232
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 229
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 225
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation 224
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 223
Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature 218
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 215
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease 212
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma 210
The evolutionary scenario of hepatocellular carcinoma in Italy: an update 209
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma 205
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 204
Transjugular Intrahepatic Portosystemic Shunt: Devices Evolution, Technical Tips and Future Perspectives 202
Post COVID-19 irritable bowel syndrome 201
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series 200
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients 196
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 195
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis 192
Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: A systematic review and meta-analysis 190
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma 190
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study 187
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 187
The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations 186
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 183
Growth and nutritional evaluation in children with chronic liver disease (CLD) before and after liver transplantation 183
Gut microbiota and metabolic syndrome 183
EFFICACY OF CERTOLIZUMAB PEGOL FOR DISEASE CONTROL OF PATIENTS AFFECTED BY ENTEROPATHIC SPONDYLARTHRITIS FOLLOWED BY THE JOINT GASTRO-RHEUMATOLOGICAL CLINIC 178
Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study 177
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 177
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 176
Hepatic steatosis in obese patients: clinical aspects and prognostic significance 176
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma 176
Review article:the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods 176
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 173
From Listing to Recovery: A Review of Nutritional Status Assessment and Management in Liver Transplant Patients 171
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 170
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 170
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder 169
Transient Elastography (FibroScan) Is Not Correlated With Liver Fibrosis but With Cholestasis in Patients With Long-Term Home Parenteral Nutrition 169
Creatine Supplementation to Improve Sarcopenia in Chronic Liver Disease: Facts and Perspectives 166
A new point-of-care portable immunosensor for non-invasive assessment of oro-ileal transit time by oral fluid tauroursodeoxycholate measurement after its oral load 166
Predictive factors for hepatocellular carcinoma recurrence after curative treatments 164
The management of endoscopic retrograde cholangiopancreatography related infections risk: results of an italian survey at regional level 164
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 164
Gut microbiota and its pathophysiology in disease paradigms 164
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease 163
Unlocking the Power of Late-Evening Snacks: Practical Ready-to-Prescribe Chart Menu for Patients with Cirrhosis 162
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 156
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 156
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 155
Clinical presentation of celiac disease and diagnosis accuracy in a single-center european pediatric cohort over 10 years 155
Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice 154
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness 153
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 152
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 151
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 151
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 150
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 149
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference 148
A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease 144
Liver fibrosis by FibroScan(®) independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes 144
Dysbiosis in Celiac disease patients with persistent symptoms on gluten-free diet: a condition similar to that present in irritable bowel syndrome patients? 142
Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL) 140
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation 140
Association between lower plasma adiponectin levels and higher liver stiffness in type 2 diabetic individuals with nonalcoholic fatty liver disease: an observational cross-sectional study 139
Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma 139
Benign hepatic nodular lesions after treatment for childhood cancer 138
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study 137
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 136
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon 133
Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance 131
Suppressing, stimulating and/or inhibiting: The evolving management of HCC patient after liver transplantation 130
Probiotics, Prebiotics and Other Dietary Supplements for Gut Microbiota Modulation in Celiac Disease Patients 130
Corrigendum to “Idiopathic pulmonary fibrosis and intestinal disorders: An observational study” [Ann Diagn Pathol 62 (2023) 152072] (Annals of Diagnostic Pathology (2023) 62, (S1092913422001745), (10.1016/j.anndiagpath.2022.152072)) 129
The role of liver and spleen elastography in advanced chronic liver disease 128
A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study 127
The role of Spleen Stiffness measurement as predictor of HCC recurrence after curative resection in cirrhotic patients 127
Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease 126
Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations 126
Prognostic factors for hepatocellular carcinoma recurrence 125
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 125
Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients 125
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT 124
Porto-sinusoidal vascular disorder in surgical candidates for liver metastases: Prevalence, noninvasive diagnosis, and burden on surgical outcomes. 123
Transjugular intrahepatic portosystemic shunt: A case report of rescue management of unrestrainable variceal bleeding in a pregnant woman 122
Totale 19.999
Salva come PNG Salva come JPEG
Categoria #
all - tutte 186.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 186.945
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.566 35 27 12 8 34 29 743 185 338 48 754 353
2022/20231.813 307 184 151 85 162 208 46 249 211 30 87 93
2023/20242.351 30 91 133 139 469 157 129 220 364 140 130 349
2024/20257.601 141 33 55 540 1.415 1.030 683 358 1.029 447 611 1.259
2025/202619.034 956 761 1.916 2.725 1.323 1.085 2.194 1.034 3.258 1.434 1.338 1.010
2026/2027552 552 0 0 0 0 0 0 0 0 0 0 0
Totale 34.691